School of Pharmacy / Social Pharmacy, Faculty of Health Sciences, Kuopio Campus, University of Eastern Finland, P.O.Box 1627, FI-70211, Kuopio, Finland.
BMC Health Serv Res. 2020 Feb 3;20(1):82. doi: 10.1186/s12913-020-4894-3.
Generic substitution (GS) was introduced in Finland in 2003 and supplemented with a reference price system (RPS) in 2009. Patients play a vital role in the acceptance of GS and the use of less expensive generic medicines. The objective of this study was to explore Finnish pharmacy customers' experience with allowing and refusing GS. Specific aims were to investigate the reasons for (1) allowing and (2) refusing GS and (3) to determine the prescription medicine-related factors influencing the customer's choice of an interchangeable prescription medicine.
A questionnaire survey was conducted in February 2018. Questionnaires were handed out from 18 community pharmacies across Finland to customers ≥18 years who purchased for themselves a prescription medicine included in the RPS. A descriptive approach was used in the analysis using frequencies, the Chi-square test and Fisher's exact test.
The final study material consisted of 1043 questionnaires (response rate 40.0%). Of the customers, 47.9% had both allowed and refused GS, 41.2% had only allowed GS and 6.0% had only refused GS. Customers had allowed GS because they wanted to lower their medicine expenses (75.5%), or because the prescribed medicine (30.8%) or medicine they had used before (27.4%) was unavailable at the pharmacy. The main reasons for refusing GS were an insignificant price difference between interchangeable medicines (63.3%) and satisfaction with the medicine used before (60.2%). The main factors influencing customers' choice of an interchangeable prescription medicine were price (81.1%), familiarity (38.4%) and availability (32.8%). Customers who had allowed GS chose the medicine based on price. Customers who had only refused GS appreciated familiarity more than the price of the medicine.
GS is a common practice in Finnish community pharmacies. The price of the medicine was the most important factor affecting customers' decision to allow or refuse GS and the choice of an interchangeable prescription medicine. Thus, customers should receive information about medicine prices at the pharmacy in order to help them make their decision. However, individual needs should also be taken into account in counselling because customers regard several factors as important in their choice of an interchangeable medicine.
2003 年,芬兰引入了通用替代(GS),并于 2009 年补充了参考定价系统(RPS)。患者在接受 GS 和使用更便宜的仿制药方面发挥着至关重要的作用。本研究的目的是探讨芬兰药房顾客对允许和拒绝 GS 的体验。具体目的是调查(1)允许和(2)拒绝 GS 的原因,并确定影响顾客选择可互换处方药的处方药相关因素。
2018 年 2 月进行了一项问卷调查。从芬兰各地的 18 家社区药店向年龄在 18 岁以上的自行购买 RPS 中处方药的顾客发放了问卷。使用频率、卡方检验和 Fisher 确切检验进行分析,采用描述性方法。
最终研究材料包括 1043 份问卷(回应率为 40.0%)。在顾客中,47.9%的人同时允许和拒绝 GS,41.2%的人仅允许 GS,6.0%的人仅拒绝 GS。顾客允许 GS 的原因是希望降低药品费用(75.5%),或者因为药房无法提供处方药品(30.8%)或以前使用的药品(27.4%)。拒绝 GS 的主要原因是可互换药品之间的价格差异不大(63.3%)和对以前使用的药品满意(60.2%)。影响顾客选择可互换处方药的主要因素是价格(81.1%)、熟悉度(38.4%)和可获得性(32.8%)。允许 GS 的顾客根据价格选择药品。只拒绝 GS 的顾客比药品价格更看重熟悉度。
GS 是芬兰社区药店的常见做法。药品价格是影响顾客允许或拒绝 GS 以及选择可互换处方药的最重要因素。因此,为了帮助顾客做出决定,他们应该在药店获得有关药品价格的信息。然而,在咨询时也应考虑个人需求,因为顾客认为在选择可互换药品时有几个因素很重要。